Novartis (NOVN.VX)

Novartis (NOVN.VX) Trading on MT5 at XM

At XM we offer Novartis (NOVN.VX) stocks as cash CFDs. Our cash CFDs stocks are undated transactions that aim to replicate the cash price of the underlying stock, and so they are adjusted for any relevant corporate actions.

Open a Demo Account
Open an Account

Risk warning: FX and CFD trading involves a high risk of loss.

About Novartis (NOVN.VX) Trading

Novartis International AG is a multinational pharmaceutical company founded in 1996 and based in Basel, Switzerland. In 2015, it ranked as the world’s largest healthcare company based on its market capitalization. Novartis manufactures a large number of generic drugs, over-the-counter medicines, vaccines, consumer health related pharmaceuticals, and animal health related products.

The company stock, NOVN.VX, is traded on the on the SIX Swiss Exchange.

Trading Conditions

Margin requirement 10 %
Spreads as low as 0.34
Symbols Novartis
Description Novartis
Min. Price Fluctuation 0.01000
Value of Minimum Price Fluctuation CHF 0.1
Value of 1 lot 10 Shares
Min/Max Trade Size 0.6/109
Swap Value in Margin Currency Long -2.17 %
Swap Value in Margin Currency Short -3.83 %
Limit and Stop Levels** 0.04
Total Volume Limit (per client)*** 1093
Weekday 10:10-18:15 (GMT +3)
Monday Open 10:10 (GMT +3)   │   Friday Close 18:15 (GMT +3)
** Min. level for placing pending orders at a current market price.

*** Note that the maximum trading volume for Novartis per client is 1093 lots. This limit will be reviewed on a daily basis and updated according to the value of the instrument.

How to Start Trading Novartis (NOVN.VX)?

Step 1

Open an XM Real Account

Step 2

Download and login to the MT5 platform

Step 3

Double-click on Novartis (NOVN.VX) from the “Market Watch” to open an order for this instrument.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.